iPhoneAlle anzeigen
iPhone 11iPhone 11 ProiPhone 11 Pro MaxiPhone 12iPhone 12 ProiPhone 12 Pro MaxiPhone 12 miniiPhone 13iPhone 13 ProiPhone 13 Pro MaxiPhone 13 miniiPhone 14iPhone 14 PlusiPhone 14 ProiPhone 14 Pro MaxiPhone 15iPhone 15 PlusiPhone 15 ProiPhone 15 Pro MaxiPhone 16iPhone 16 PlusiPhone 16 ProiPhone 16 Pro MaxiPhone 16eiPhone 8iPhone 8 PlusiPhone SE 2020iPhone SE 2022iPhone XiPhone XRiPhone XSiPhone XS Max
Galaxy A-SerieAlle anzeigen
Galaxy A12Galaxy A13Galaxy A13 5GGalaxy A14Galaxy A15Galaxy A16Galaxy A17 5GGalaxy A20eGalaxy A21Galaxy A22Galaxy A23Galaxy A24Galaxy A25Galaxy A26 5GGalaxy A32Galaxy A33Galaxy A34Galaxy A35Galaxy A36 5GGalaxy A40Galaxy A41Galaxy A42Galaxy A50Galaxy A51Galaxy A52Galaxy A53Galaxy A54Galaxy A55Galaxy A56 5GGalaxy A70Galaxy A71Galaxy A72
Redmi SeriesAlle anzeigen
Redmi 10Redmi 13CRedmi 15 5GRedmi Note 10Redmi Note 10 ProRedmi Note 11Redmi Note 11 ProRedmi Note 11 Pro Plus 5GRedmi Note 11sRedmi Note 12Redmi Note 12 5GRedmi Note 12 ProRedmi Note 12 Pro 5GRedmi Note 12 Pro PlusRedmi Note 13Redmi Note 13 5GRedmi Note 13 ProRedmi Note 13 Pro PlusRedmi Note 14Redmi Note 14 Pro PlusRedmi Note 8Redmi Note 8 ProRedmi Note 9Redmi Note 9 Pro
- Startseite
Bücher Wissen & Bildung Naturwissenschaft, Medizin, Informatik, Technik Biologie Allg. & Lexika Impact of COVID-19 and Non-COVID-19 Vaccination in Special Populations
Derzeit nicht verfügbar
Handgeprüfte Gebrauchtware
Bis zu 50 % günstiger als neu
Der Umwelt zuliebe
Impact of COVID-19 and Non-COVID-19 Vaccination in Special Populations
(Gebundene Ausgabe, Englisch)
★★★★★
☆☆☆☆☆ Keine Bewertungen vorhanden
Optischer Zustand
Beschreibung
Vaccination is crucial for reducing morbidity and mortality; however, vaccine hesitancy poses a significant challenge, often driven by a lack of confidence in vaccine safety and efficacy. The World Health Organization defines vaccine hesitancy as the delay in acceptance or refusal of vaccines despite their availability. To enhance vaccination uptake, it is vital to provide evidence demonstrating… vaccine safety and efficacy, especially for populations prone to hesitancy. This Special Issue focuses on four specific groups: children, older adults, patients with comorbid conditions, and risk-averse individuals. Research highlighted in this issue reveals that the COVID-19 vaccines generally have high efficacy and low serious adverse event rates in children. Older adults often lack adequate vaccination guidelines tailored to their specific health needs, stressing the necessity for more comprehensive recommendations. Additionally, patients with autoimmune diseases showed impaired immunity to vaccines, though a second dose proved beneficial without increasing adverse events. Moreover, risk-averse individuals demonstrated anxiety during vaccinations, particularly those with severe allergies, but this could be alleviated in controlled environments. Lastly, those with prior COVID-19 infections experienced "pandemic fatigue," elevating their vaccine hesitancy. The findings underscore the need for targeted education and support to encourage vaccination across these diverse populations, ultimately preserving public health and preventing societal disruptions. Dieses Produkt haben wir gerade leider nicht auf Lager.
Handgeprüfte Gebrauchtware
Bis zu 50 % günstiger als neu
Der Umwelt zuliebe
Technische Daten
Erscheinungsdatum
17.08.2025
Sprache
Englisch
EAN
9783725826469
Einbandart
Gebundene Ausgabe
Höhe
250 mm
Breite
175 mm
-.-
★★★★★
☆☆☆☆☆ Leider noch keine Bewertungen
Leider noch keine Bewertungen
Sicher bei rebuy kaufen
Schreib die erste Bewertung für dieses Produkt!
Wenn du eine Bewertung für dieses Produkt schreibst, hilfst du allen Kund:innen, die noch überlegen, ob sie das Produkt kaufen wollen. Vielen Dank, dass du mitmachst!
Sicher bei rebuy kaufen